Evidence map›Paper›PMID 38378908›Full record

ArticleJournal of neurology2024

A Delphi consensus to identify the key screening tests/questions for a digital neurological examination for epidemiological research.

Vasco Ribeiro Ferreira, Carol Brayne, Paolo Ragonese, Carlos Ketzoian, Marta Piccioli, Lorenzo Tinti, Carlo Casali, Cherubino di Lorenzo, Claudia Ramos, João Azevedo and 6 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 6 countries.

Vasco Ribeiro FerreiraDepartment of Sustainable Health, University of Groningen, Campus Fryslân, Wirdumerdijk 34, 8911 CE, Leeuwarden, The Netherlands. v.ribeiro.ferreira@rug.nl.ORCID http://orcid.org/0000-0001-7060-9733
Carol BrayneCambridge Public Health, University of Cambridge, Cambridge, United Kingdom.
Paolo RagoneseDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, Palermo, Italy.
Carlos KetzoianInstitute of Neurology, School of Medicine, Neuroepidemiology Section, University of the Republic, Montevideo, Uruguay.
Marta PiccioliUOC of Neurology, PO San Filippo Neri, ASL Roma 1, Rome, Italy.
Lorenzo TintiLaboratory of Neurology, Mario Negri Institute for Pharmacological Research (IRCCS), Milan, Italy.
Carlo CasaliDepartment of Medico-Surgical Sciences and Biotechnologies (SBMC), University Rome Sapienza, Rome, Italy.
Cherubino di LorenzoDepartment of Medico-Surgical Sciences and Biotechnologies (SBMC), University Rome Sapienza, Rome, Italy.
Claudia RamosGrupo de Neurociencias de Antioquia (GNA), Faculty of Medicine, University of Antioquia, Medellín, Colombia.
João AzevedoAgrupamento de Centros de Saúde de Gaia, Unidade de Saúde Familiar Nova Salus, Vila Nova de Gaia, Portugal.
Adriana GomesHospital de Braga, EPE, Braga, Portugal.
Roderick StewartParkinson's UK, London, United Kingdom.
Hein HaasParkinson Vereniging, Bunnik, The Netherlands.
Stan HoppenbrouwerParkinson Vereniging, Bunnik, The Netherlands.
Esther MettingUniversity Medical Center Groningen, Groningen, The Netherlands.
Valentina GalloDepartment of Sustainable Health, University of Groningen, Campus Fryslân, Wirdumerdijk 34, 8911 CE, Leeuwarden, The Netherlands.
University of Groningen · NLAdministração Regional de Saúde de Lisboa e Vale do Tejo · PTASL Roma · ITHospital Braga · PTMario Negri Institute for Pharmacological Research · ITParkinson's UK · GBUniversidad de Antioquia · COUniversidad de la República de Uruguay · UYUniversity Medical Center Groningen · NLUniversity of Cambridge · GBUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost neurological diseases have no curative treatment; therefore, focusing on prevention is key. Continuous research to uncover the protective and risk factors associated with different neurological diseases is crucial to successfully inform prevention strategies. eHealth has been showing promising advantages in healthcare and public health and may therefore be relevant to facilitate epidemiological studies.

objectiveIn this study, we performed a Delphi consensus exercise to identify the key screening tests to inform the development of a digital neurological examination tool for epidemiological research.

methodsTwelve panellists (six experts in neurological examination, five experts in data collection-two were also experts in the neurological examination, and three experts in participant experience) of different nationalities joined the Delphi exercise. Experts in the neurological examination provided a selection of items that allow ruling out neurological impairment and can be performed by trained health workers. The items were then rated by them and other experts in terms of their feasibility and acceptability.

resultsTen tests and seven anamnestic questions were included in the final set of screening items for the digital neurological examination. Three tests and five anamnestic questions were excluded from the final selection due to their low ratings on feasibility.

conclusionThis work identifies the key feasible and acceptable screening tests and anamnestic questions to build an electronic tool for performing the neurological examination, in the absence of a neurologist.

Indexed as

Delphi TechniqueNervous System DiseasesNeurologic ExaminationEpidemiologic StudiesFemaleHumanseHealthEpidemiologyNeuroepidemiologyNeurological diseases

Identifiers

PMID38378908
PMCPMC11055750
OpenAlexW4391953988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.